SCHEMBL407917

SCHEMBL407917

FC(F)(F)c1ccc2n[c]ccc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.51
KDM4E B2RXH2 1/20 0.43
EPHX2 P34913 1/20 0.41
SCN4A P35499 1/20 0.41
CCNE2 O96020 1/20 0.39
CCNA2 P20248 1/20 0.39
CCNE1 P24864 1/20 0.39
CDK2 P24941 1/20 0.39
CCNA1 P78396 1/20 0.39
HRH3 Q9Y5N1 1/20 0.38
PKM P14618 1/20 0.38
NPBWR1 P48145 3/20 0.37
METAP2 P50579 1/20 0.36
DGAT1 O75907 2/20 0.36
KCNH2 Q12809 2/20 0.36
DYRK1A Q13627 2/20 0.34
DYRK1B Q9Y463 1/20 0.34
CBFB Q13951 1/20 0.34
SCN10A Q9Y5Y9 1/20 0.33
CSNK1D P48730 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL406456 0.85 BACE1 (0.43) BACE1KDM4EEPHX2SCN4ACCNE2
SCHEMBL16992698 0.82 SCN9A (0.45) BACE1KDM4EKCNH2SCN10A
SCHEMBL2302785 0.81 SCN10A (0.39) BACE1CDK2PKMMETAP2KCNH2
SCHEMBL16966792 0.76 THRB (0.60) KCNH2SCN10A
SCHEMBL206393 0.75 BACE1 (0.47) BACE1KDM4EPKM
SCHEMBL16288114 0.74 NPC1 (0.45) SCN4APKMDYRK1ACBFBSCN10A
SCHEMBL406855 0.73 BACE1 (0.50) BACE1KDM4EEPHX2SCN4ACCNE2
SCHEMBL5090080 0.72 BACE1 (0.62) BACE1KDM4EEPHX2SCN4AHRH3
SCHEMBL22346815 0.71 MPL (0.33) BACE1
SCHEMBL5342120 0.71 MPL (0.33) BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111201245-B Compounds, compositions, and methods 戴纳立制药公司 2024-04-05 CN claimed
CN-111094233-B Compounds, compositions, and methods 戴纳立制药公司 2024-03-15 CN claimed
EP-4248965-A2 COMPOUNDS, COMPOSITIONS AND METHODS Denali Therapeutics Inc. (US) 2023-09-27 EP claimed
EP-3676297-B1 COMPOUNDS, COMPOSITIONS AND METHODS DENALI THERAPEUTICS INC (US) 2023-05-17 EP claimed
US-20210147435-A1 COMPOUNDS, COMPOSITIONS AND METHODS DENALI THERAPEUTICS INC. 2021-05-20 US claimed
US-20200331900-A1 COMPOUNDS, COMPOSITIONS AND METHODS DENALI THERAPEUTICS INC. 2020-10-22 US claimed
EP-3676297-A1 COMPOUNDS, COMPOSITIONS AND METHODS Denali Therapeutics Inc. (US) 2020-07-08 EP claimed
EP-3665156-A1 COMPOUNDS, COMPOSITIONS AND METHODS Denali Therapeutics Inc. (US) 2020-06-17 EP claimed
CN-111201245-A Compounds, compositions and methods 戴纳立制药公司 2020-05-26 CN claimed
CN-111094233-A Compounds, compositions and methods 戴纳立制药公司 2020-05-01 CN claimed
WO-2019046779-A1 COMPOUNDS, COMPOSITIONS AND METHODS DENALI THERAPEUTICS INC. (US) 2019-03-07 WO claimed
WO-2019032743-A1 COMPOUNDS, COMPOSITIONS AND METHODS DENALI THERAPEUTICS INC. (US) 2019-02-14 WO claimed
EP-2389066-B1 CYCLOPENTADIONE DERIVED HERBICIDES SYNGENTA LTD (GB) 2017-07-05 EP claimed
EP-2387569-B1 HERBCIDES SYNGENTA LTD (GB) 2016-06-15 EP claimed
US-8895474-B2 Herbicidally active cyclopentanediones and derivatives thereof, and their use in controlling weeds SYNGENTA LIMITED (GB) 2014-11-25 US claimed
US-8865623-B2 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds SYNGENTA LIMITED (GB) 2014-10-21 US claimed
CN-118239938-A Compounds, compositions, and methods 戴纳立制药公司 2024-06-25 CN disclosed
CN-118239937-A Compounds, compositions, and methods 戴纳立制药公司 2024-06-25 CN disclosed
US-20120021912-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed
US-20120021909-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120021912-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 BACE1 1901/4885KDM4E 1092/4885EPHX2 154/4885
US-20200331900-A1 COMPOUNDS, COMPOSITIONS AND METHODS EIF4EBP1, EIF4B, EIF4E BACE1 3789/4885KDM4E 2319/4885EPHX2 1206/4885
US-20120021909-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 BACE1 1901/4885KDM4E 1092/4885EPHX2 154/4885
US-20210147435-A1 COMPOUNDS, COMPOSITIONS AND METHODS EIF4EBP1, EIF4B, EIF4E BACE1 3801/4885KDM4E 2439/4885EPHX2 1210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.